| Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy L Apetoh, F Ghiringhelli, A Tesniere, M Obeid, C Ortiz, A Criollo, G Mignot, ... Nature medicine 13 (9), 1050-1059, 2007 | 3373 | 2007 |
| Calreticulin exposure dictates the immunogenicity of cancer cell death M Obeid, A Tesniere, F Ghiringhelli, GM Fimia, L Apetoh, JL Perfettini, ... Nature medicine 13 (1), 54-61, 2007 | 3288 | 2007 |
| Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma, C Ortiz, ... Nature medicine 15 (10), 1170-1178, 2009 | 2050 | 2009 |
| The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide S Viaud, F Saccheri, G Mignot, T Yamazaki, R Daillère, D Hannani, ... science 342 (6161), 971-976, 2013 | 1989 | 2013 |
| Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice M Michaud, I Martins, AQ Sukkurwala, S Adjemian, Y Ma, P Pellegatti, ... Science 334 (6062), 1573-1577, 2011 | 1408 | 2011 |
| 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell–dependent antitumor immunity J Vincent, G Mignot, F Chalmin, S Ladoire, M Bruchard, A Chevriaux, ... Cancer research 70 (8), 3052-3061, 2010 | 1318 | 2010 |
| Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells F Chalmin, S Ladoire, G Mignot, J Vincent, M Bruchard, JP Remy-Martin, ... The Journal of clinical investigation 120 (2), 457-471, 2010 | 1134 | 2010 |
| Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 841 | 2014 |
| Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth M Bruchard, G Mignot, V Derangère, F Chalmin, A Chevriaux, F Végran, ... Nature medicine 19 (1), 57-64, 2013 | 779 | 2013 |
| Cardiac glycosides exert anticancer effects by inducing immunogenic cell death L Menger, E Vacchelli, S Adjemian, I Martins, Y Ma, S Shen, T Yamazaki, ... Science translational medicine 4 (143), 143ra99-143ra99, 2012 | 427 | 2012 |
| Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression F Chalmin, G Mignot, M Bruchard, A Chevriaux, F Végran, A Hichami, ... Immunity 36 (3), 362-373, 2012 | 371 | 2012 |
| Dual role of heat shock proteins as regulators of apoptosis and innate immunity AL Joly, G Wettstein, G Mignot, F Ghiringhelli, C Garrido Journal of innate immunity 2 (3), 238-247, 2010 | 371 | 2010 |
| In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival S Ladoire, G Mignot, S Dabakuyo, L Arnould, L Apetoh, C Rébé, ... The Journal of pathology 224 (3), 389-400, 2011 | 274 | 2011 |
| Prospects for exosomes in immunotherapy of cancer G Mignot, S Roux, C Thery, E Ségura, L Zitvogel Journal of cellular and molecular medicine 10 (2), 376-388, 2006 | 248 | 2006 |
| The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells F Végran, H Berger, R Boidot, G Mignot, M Bruchard, M Dosset, ... Nature immunology 15 (8), 758-766, 2014 | 226 | 2014 |
| Human FOXP3 and cancer F Martin, S Ladoire, G Mignot, L Apetoh, F Ghiringhelli Oncogene 29 (29), 4121-4129, 2010 | 178 | 2010 |
| Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy S Ladoire, L Arnould, G Mignot, B Coudert, C Rébé, F Chalmin, J Vincent, ... Breast cancer research and treatment 125, 65-72, 2011 | 174 | 2011 |
| Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells V Derangere, A Chevriaux, F Courtaut, M Bruchard, H Berger, F Chalmin, ... Cell Death & Differentiation 21 (12), 1914-1924, 2014 | 154 | 2014 |
| Immunogenicity of anthracyclines: moving towards more personalized medicine L Apetoh, G Mignot, T Panaretakis, G Kroemer, L Zitvogel Trends in molecular medicine 14 (4), 141-151, 2008 | 147 | 2008 |
| Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells H Bugaut, M Bruchard, H Berger, V Derangère, L Odoul, R Euvrard, ... PLoS One 8 (6), e65181, 2013 | 120 | 2013 |
